Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02053311
Recruitment Status : Withdrawn (Due to former trials, drug has not demonstrated a clinical profile sufficient to move forward in mCRPC)
First Posted : February 3, 2014
Last Update Posted : July 30, 2018
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : August 19, 2014
Estimated Study Completion Date : August 19, 2034